European Innovation Council
VC Fund
Brussels, Belgium
European Innovation Council is a VC fund in Brussels focused on Health Care and Biotechnology. The European Innovation Council aims to support top-class innovators, entrepreneurs, small companies, and researchers with bright ideas. The EIC co-invests alongside private investors in early-stage startups that have ESG impacts.
- Total investments:
- 1175
- Last investment:
- Lead investor:
- 74%
Last updated:
For AI agents: llms.txt
Industries European Innovation Council invests in
Stages European Innovation Council invests in
Countries European Innovation Council invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Baybars Altuntas
|
|||
Jacopo Losso
|
|||
Pablo Hernández
|
|||
Selma Prodanovic
|
Investment Focus
Industry
- Health Care 77 (7%)
- Biotechnology 66 (6%)
- Medical Device 55 (5%)
- Medical 44 (4%)
- Software 31 (3%)
Stage
- Grant 163 (14%)
- Funding Round 65 (6%)
- Series A 36 (3%)
- Seed 30 (3%)
- Series B 14 (1%)
Country
- France 31 (3%)
- Germany 25 (2%)
- The Netherlands 24 (2%)
- Israel 23 (2%)
- Switzerland 23 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Baybars Altuntas
Board Member
|
Board Member | Total investments: 0 | Find email | |
Candace Johnson
President
|
President | Total investments: 1 | Find email | |
|
Jacopo Losso
Director of Secretariat
|
Director of Secretariat | Total investments: 0 | Find email | |
|
Pablo Hernández
IT Expert
|
IT Expert | Total investments: 0 | Find email | |
|
Selma Prodanovic
Board Member & Vice President
|
Board Member & Vice President | Total investments: 0 | Find email | |
| See all 21 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Proteotype Diagnostics
|
Proteotype Diagnostics providing cross-sectional snapshots, like a CT scan for your blood. | $575K / Grant / Jul 30, 2026 | |
Xeltis
|
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis’ restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and for coronary artery bypass graft (CABG) surgery and pulmonary heart valves, for whichclinical trials are ongoing. Xeltis was formed through the merger of two Dutch/Swiss university spin-offs. It currently has operations in The Netherlands and in the USA. Xeltis’ investors include venture capital funds EQT Life Sciences, Kurma Partners, VI Partners and Ysios Capital as well as a number of private investors. In 2021, Xeltis secured a €15 million financing from the European Investment Bank and a €15 million funding from the European Innovation Council Accelerator (EIC) set up by the European Commission. | $23.3M / Venture - Series Unknown / Jul 28, 2026 | |
|
Xeltis
|
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis’ restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and for coronary artery bypass graft (CABG) surgery and pulmonary heart valves, for whichclinical trials are ongoing. Xeltis was formed through the merger of two Dutch/Swiss university spin-offs. It currently has operations in The Netherlands and in the USA. Xeltis’ investors include venture capital funds EQT Life Sciences, Kurma Partners, VI Partners and Ysios Capital as well as a number of private investors. In 2021, Xeltis secured a €15 million financing from the European Investment Bank and a €15 million funding from the European Innovation Council Accelerator (EIC) set up by the European Commission. | $23.3M / Venture - Series Unknown / Jul 28, 2026 | |
Sensity AI
|
The Visual Threat Intelligence Platform. Deep learning for monitoring and detecting #deepfakes. | $5.6M / Grant / Jul 17, 2026 | |
Syntetica
|
Syntetica is a materials technology and climate technology company that develops chemical recycling technology for synthetic textiles. It uses proprietary green chemistry to convert nylon textile waste into virgin-quality recycled polymers, enabling circular production for the textile, automotive, and industrial materials industries. Its mission isto decarbonize synthetic materials by making high-quality recycled feedstocks commercially viable.The company's proprietary chemical depolymerization process separates and recovers Nylon 6 and Nylon 6,6 from blended textile waste that would otherwise be difficult to recycle. The process operates under low-temperature, low-pressure conditions, removes dyes and finishes, and produces recycled raw materials that can be reintroduced into manufacturing without compromising quality. Syntetica's technology supports textile-to-textile recycling and is designed to reduce carbon emissions, landfill waste, and reliance on virgin fossil-based materials. | $30M / Series A / Jul 16, 2026 | |
Nanovel
|
Nanovel Ltd. is a pioneer in the field of autonomous harvesting of deep foliage tree fruit. Isaac Mazor , Founder and CEO and the Nanovel team of top notch experts in AI and robotics technologies, are driven by the enormous need for innivation in fresh fruit harvesting. Nanovel's proprietary solution combines AI, computer vision, machinelearning and proprietary robotics solutions, to enable autonomous tree fruit harvesting to become more productive, reliable and cost effective than hand harvesting | $2.9M / Grant / Jul 15, 2026 | |
e-peas
|
e-peas is a disruptive semiconductor company that enables the seamless operation of all connected nodes. The company is developing ultra-low-power high performances circuits such as energy harvester interfaces and microcontrollers that help companies make their IoT devices smarter and more energy-efficient by either prolonging battery life ormaking the devices live forever. e-peas also develops energy harvesting solutions which extend rechargeable batteries' life of portable devices by harvesting energy from solar, thermal, vibration, radiofrequency, and other sources. These solutions help industries to build products that free users and industries from a burden of replacing non-rechargeable batteriesThe company was founded in 2014 and is headquartered in Mont-saint-guibert, Brabant Wallon, Belgium. | $21.9M / Venture - Series Unknown / Jul 08, 2026 | |
VSORA
|
VSORA is an IP provider for chipmakers designing the latest generations of digital communications systems, like 5G. Our powerful multi-core DSP architecture eliminates the need for DSP co-processors to provide a level of flexibility achievable only with software programming. A new DSP development flow allows signal processing engineers and softwareengineers to share the same environment and source code, dramatically accelerating time-to-market. Their mission is to meet the technical challenges by providing a state-of-the-art DSP design process and boosting the DSP computing power while simultaneously optimizing power consumption and system performance, and reducing the silicon footprint. Based in France, the company was founded in 2015 by a team of highly qualified and accomplished DSP engineers with combined experience of more than 70 years. | Venture - Series Unknown / Jul 01, 2026 | |
iPremom
|
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia. | $2.8M / Grant / Jun 30, 2026 | |
RarEarth
|
RarEarth paves the way for rare earth recycling | $2.8M / Grant / Jun 25, 2026 | |
| See all 1175 investments → | |||
Co-Investors
European Innovation Council
114 deals together
Bpifrance
16 deals together
Invest-NL
9 deals together
Quantonation
9 deals together
EIC Accelerator
8 deals together
Crédit Mutuel Innovation
7 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does European Innovation Council invest in?
European Innovation Council invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Grant and Funding Round stage. Most of the 1,175 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact European Innovation Council?
Public channels for European Innovation Council include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at European Innovation Council?
The team at European Innovation Council includes Baybars Altuntas (Board Member), Candace Johnson (President) and Jacopo Losso (Director of Secretariat), among 21 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
